cilostazol has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kureshiro, J; Kusunoki, S; Miyamoto, K; Tanaka, N | 1 |
1 other study(ies) available for cilostazol and myelin oligodendrocyte glycoprotein (35-55)
Article | Year |
---|---|
Selective phosphodiesterase-3 inhibitor cilostazol ameliorates experimental autoimmune encephalomyelitis.
Topics: Animals; Cilostazol; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Glycoproteins; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-10; Interleukin-17; Lymph Nodes; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; P-Selectin; Peptide Fragments; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Severity of Illness Index; T-Lymphocytes; Tetrazoles; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2009 |